The original success of Viagra undeniably reshaped the drug landscape, but investing in companies heavily reliant on generic versions presents a complex picture. Although early earnings were substantial, the end of patents and the emergence of less expensive alternatives have weakened market share. Thus, a thorough assessment of present financial p